AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Down 31.1% in January

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 291,500 shares, a drop of 31.1% from the December 31st total of 423,300 shares. Based on an average daily volume of 465,900 shares, the short-interest ratio is presently 0.6 days. Currently, 7.7% of the shares of the stock are sold short.

AquaBounty Technologies Trading Up 3.8 %

Shares of NASDAQ:AQB traded up $0.03 during midday trading on Friday, hitting $0.72. The company had a trading volume of 89,344 shares, compared to its average volume of 299,068. The company has a current ratio of 3.02, a quick ratio of 2.98 and a debt-to-equity ratio of 0.05. AquaBounty Technologies has a 12 month low of $0.47 and a 12 month high of $2.79. The firm has a fifty day simple moving average of $0.78 and a 200 day simple moving average of $1.06. The stock has a market cap of $2.78 million, a price-to-earnings ratio of -0.04 and a beta of 1.17.

AquaBounty Technologies (NASDAQ:AQB) last issued its earnings results on Tuesday, November 5th. The company reported ($0.88) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.88). The firm had revenue of $0.05 million for the quarter, compared to analysts’ expectations of $0.10 million. AquaBounty Technologies had a negative return on equity of 18.20% and a negative net margin of 5,842.69%. During the same quarter last year, the business earned ($1.60) earnings per share.

Institutional Inflows and Outflows

An institutional investor recently raised its position in AquaBounty Technologies stock. Epiq Partners LLC lifted its holdings in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 423.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 89,000 shares of the company’s stock after purchasing an additional 72,000 shares during the quarter. Epiq Partners LLC owned 2.30% of AquaBounty Technologies worth $56,000 at the end of the most recent quarter. Institutional investors own 8.92% of the company’s stock.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.